Cohen G H, Wilcox W C, Sodora D L, Long D, Levin J Z, Eisenberg R J
Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia 19104-6003.
J Virol. 1988 Jun;62(6):1932-40. doi: 10.1128/JVI.62.6.1932-1940.1988.
Glycoprotein D (gD) is a viron envelope component of herpes simplex virus types 1 and 2. We have previously defined seven monoclonal antibody (MAb) groups which recognize distinct epitopes on the mature gD-1 protein of 369 amino acids. MAb groups VII, II, and V recognize continuous epitopes at residues 11-19, 272-279, and 340-356, respectively. MAb groups I, III, IV, and VI recognize discontinuous epitopes. Recent studies have focused on epitopes I, III, and VI. Using truncated forms of gD generated by recombinant DNA methods and proteolysis, epitopes III, IV, and VI were located within amino acids 1-233. A portion of discontinuous epitope I was located in a region within residues 233-275. For this study, we used recombinant DNA methods to create mutations in the gD-1 gene and studied the effects of those mutations on gD as expressed in mammalian cells. Plasmid pRE4, containing the coding sequence of gD-1 and the Rous sarcoma virus long terminal repeat promoter, was transfected into mammalian cells. The expressed protein, gD-1-(pRE4), was identical in size and antigenic properties to gD-1 from infected cells. Six in-frame deletion mutations were subsequently constructed by using restriction enzymes to excise portions of the gD-1 gene. Plasmids carrying these mutated forms were transfected into cells, and the corresponding proteins were examined at 48 h posttransfection for antigenicity and glycosylation patterns. Three deletions of varying size were located downstream of residue 233. Analysis of these mutants showed that amino acids within the region 234-244 were critical for binding of DL11 (group I), but not for other MAb groups. Three other deletion mutants lost all ability to bind MAbs which recognize discontinuous epitopes. In addition, much of the gD expressed by these mutants was observed to migrate as high-molecular-weight aggregated forms in nondenaturing gels. Each of these mutations involved the loss of a cysteine residue, suggesting that disulfide linkages play an essential role in the formation of discontinuous epitopes. The extent of glycosylation of the mutant gD molecules accumulated at 48 h posttransfection suggested altered carbohydrate processing. In one case, there was evidence for increased O-linked glycosylation. Those proteins which had lost a cysteine residue as part of the deletion did not accumulate molecules processed beyond the high-mannose stage. The results suggest that carbohydrate processing during synthesis of gD is very sensitive to alterations in structure, particularly changes involving cysteine residues.
糖蛋白D(gD)是1型和2型单纯疱疹病毒的病毒包膜成分。我们之前定义了七个单克隆抗体(MAb)组,它们识别369个氨基酸的成熟gD-1蛋白上不同的表位。MAb组VII、II和V分别识别第11 - 19、272 - 279和340 - 356位残基处的连续表位。MAb组I、III、IV和VI识别不连续表位。最近的研究集中在表位I、III和VI上。利用重组DNA方法和蛋白酶解产生的gD截短形式,表位III、IV和VI位于氨基酸1 - 233内。不连续表位I的一部分位于第233 - 275位残基区域内。在本研究中,我们利用重组DNA方法在gD-1基因中产生突变,并研究这些突变对在哺乳动物细胞中表达的gD的影响。将含有gD-1编码序列和劳斯肉瘤病毒长末端重复启动子的质粒pRE4转染到哺乳动物细胞中。表达的蛋白gD-1-(pRE4)在大小和抗原特性上与感染细胞中的gD-1相同。随后利用限制酶切除gD-1基因的部分片段构建了六个读码框内缺失突变。携带这些突变形式的质粒被转染到细胞中,并在转染后48小时检测相应蛋白的抗原性和糖基化模式。三个不同大小的缺失位于第233位残基下游。对这些突变体的分析表明,234 - 244区域内的氨基酸对于DL11(I组)的结合至关重要,但对其他MAb组则不然。另外三个缺失突变体失去了与识别不连续表位抗体结合的所有能力。此外,在非变性凝胶中观察到这些突变体表达的许多gD以高分子量聚集形式迁移。这些突变中的每一个都涉及一个半胱氨酸残基的缺失,表明二硫键在不连续表位的形成中起重要作用。转染后48小时积累突变gD分子的糖基化程度表明碳水化合物加工发生了改变。在一个案例中,有证据表明O-连接糖基化增加。那些作为缺失一部分而失去半胱氨酸残基的蛋白没有积累超过高甘露糖阶段加工的分子。结果表明,gD合成过程中的碳水化合物加工对结构改变非常敏感,特别是涉及半胱氨酸残基的变化。